Esra @esrajustesra.bsky.social · 09/10/2025Metavivor is a great place to donate if you'd like to actually support metastatic breast cancer research. #Stage4NeedsMore @metavivor.bsky.social 000
Esra @esrajustesra.bsky.social · 09/10/2025www.fiercebiotech.com/cro/spanish-... MEDSIR will use the Ataraxis Breast platform developed by the New York AI company, which combines pathology results and clinical data to forecast how patients will respond to different treatments.fiercebiotech.comSpanish oncology research group MEDSIR infuses AI into breast cancer trialsSpanish oncology research outfit Medica Scientia Innovation Research (MEDSIR) is infusing artificial intelligence into its breast cancer trials 000
Reposted by EsraStacey Tinianov, MPH @coffeemommy.bsky.social · 27/06/2025We start anti-cancer therapies at the highest dose but start supportive care interventions at the lowest dose... WHY? asks @evaschumacherwulf.bsky.social #MASCC25 #QoL 1112
Esra @esrajustesra.bsky.social · 25/06/2025Another very informative webinar on lobular metastatic breast cancer (mILC) by @sherryshenmd.bsky.social Thank you so much for your time! @lobularbca.bsky.social 020
Reposted by EsraNPR @npr.org · 16/06/2025A new study shows that music therapy is as effective as cognitive behavioral therapy at helping cancer patients and survivors heal emotionally. n.pr/45rG55Cn.prThe doctor said 'be happy.' Music therapy can help cancer patients do thatA new study shows that music therapy is as effective as cognitive behavioral therapy at helping cancer patients and survivors heal emotionally. 32648128
Esra @esrajustesra.bsky.social · 11/06/2025A big thank you to Dr. Mouabbi @jamouabbi.bsky.social and Dr. Shen @sherryshenmd.bsky.social for your time and wonderful presentations on lobular cancer. Thank you @graspcancer.bsky.social for organizing these sessions! 011
Esra @esrajustesra.bsky.social · 09/06/2025Inhibition of NR2F2 restores hormone therapy response to endocrine refractory breast cancers | Science Translational Medicine www.science.org/doi/10.1126/...science.orgInhibition of NR2F2 restores hormone therapy response to endocrine refractory breast cancersNR2F2 modulates the ER cistrome, coregulator interactions, and chromatin accessibility to promote endocrine resistance in ER+ breast cancer. 000
Esra @esrajustesra.bsky.social · 09/06/2025Chemo is like dementors from Harry Potter. It sucks the life out of you. No amount of chocolate helps. 😩 000
Reposted by EsraMemorial Sloan Kettering Cancer Center @mskcancercenter.bsky.social · 31/05/2025Stop by gynecologic oncologist Dr. Alison Schram's poster session on "PYNNACLE phase 2 clinical trial of rezatapopt in patients with advanced solid tumors harboring a TP53 Y220C mutation" TODAY at 9am. #ASCO25. @ascocancer.bsky.social 054
Reposted by EsraDawn Richards, PhD @dawnrichards.bsky.social · 10/04/2025"Patient and public involvement in research reporting" - and the case for why we need to do better www.bmj.com/content/389/.... Grateful to have been part of this editorial team with S. Staniszewska, S. Hopewell and R. Chidebe #PatientEngagement #PPI #ConsumerInvolvementbmj.comPatient and public involvement in research reportingMore focus needed to improve PPI reporting in research Patient and public involvement (PPI) has become a key part of health and social care research in many countries with a focus on working with or ... 2155
Reposted by EsraSarah Sammons MD @drsarahsammons.bsky.social · 06/04/2025How does SG perform in active BC brain metastases? Sacituzumab govitecan (SG) in 33 patients with HER2-negative MBC and CNS metastases, including active and LMD had a modest CNS ORR of 4/30 (13%) and median CNS-PFS of 2.9 months (95%CI:2.0-4.3). pubmed.ncbi.nlm.nih.gov/40038301/pubmed.ncbi.nlm.nih.govReal-World outcomes with sacituzumab govitecan among breast cancer patients with central nervous system metastases - PubMedCentral nervous system (CNS) metastases are associated with poor prognosis in patients with metastatic breast cancer (MBC). In this retrospective study, we investigated the activity of sacituzumab gov... 141
Esra @esrajustesra.bsky.social · 10/03/2025The first-in-class KIT6 inhibitor PF-07248144 in combination with fulvestrant: "KAT6A inhibition could repress ER gene transcription and overcome ESR1 mutations that promote endocrine therapy resistance." #metastaticbreastcancer #stage4needsmore www.onclive.com/view/pf-0724...onclive.comPF-07248144 Plus Fulvestrant Is Safe, Active in Pretreated ER+/HER2– Metastatic Breast CancerPF-07248144 plus fulvestrant was safe and generated responses in pretreated estrogen receptor–positive, HER2-negative metastatic breast cancer. 010
Esra @esrajustesra.bsky.social · 25/02/2025And you receive a letter starting with "We are sorry to tell you about a privacy event." Seriously?! 000
Reposted by EsraSarah Sammons MD @drsarahsammons.bsky.social · 23/02/2025Boswellia aka Indian frankincense or olibanum, is a tree native to India. In a clinical trial, it was safe and effective for radiation induced necrosis of brain metastases which is a common problem! #medsky www.redjournal.org/article/S036...redjournal.orgBoswellia serrata for cerebral radiation necrosis after radiosurgery for brain metastasesRadiation necrosis(RN) is a dose-limiting toxicity of stereotactic radiosurgery(SRS) for brain metastases. Oral corticosteroids are not optimal for long-term management given multiple side effects. Bo... 2104
Esra @esrajustesra.bsky.social · 17/02/2025😕 Sigh. I look at this and tear up that Ellie is not included 😢 000
